Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins
- 23 March 1991
- journal article
- research article
- Published by Elsevier
- Vol. 337 (8743) , 685-689
- https://doi.org/10.1016/0140-6736(91)90275-t
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antibody against epstein‐barr virus dna polymerase activity in sera of patients with nasopharyngeal carcinomaJournal of Medical Virology, 1989
- Antibody to Epstein‐Barr virus‐specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in TaiwanJournal of Medical Virology, 1989
- Relationship between nasopharyngeal carcinoma and high antibody titers to epstein‐barr virus‐specific thymidine kinaseInternational Journal of Cancer, 1989
- Epstein--Barr Virus Gene Expression in Nasopharyngeal CarcinomaJournal of General Virology, 1988
- Epstein-Barr Virus-specific Transcription in Normal and Malignant Nasopharyngeal Biopsies and in Lymphocytes from Healthy Donors and Infectious Mononucleosis PatientsJournal of General Virology, 1987
- Detection of epstein‐barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiographyInternational Journal of Cancer, 1983
- Follow-Up Studies on Epstein – Barr virus IgA/VCA Antibody-Positive Persons in Zangwu County, ChinaIntervirology, 1983
- Antibody responses to epstein‐barr virus‐specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinomaInternational Journal of Cancer, 1982
- Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.Proceedings of the National Academy of Sciences, 1980
- Histopathology of nasopharyngeal carcinoma.Correlations with epidemiology, survival rates and other biological characteristicsCancer, 1979